A study evaluating associations of biologic and small-molecule therapies with incident cancer in rheumatoid arthritis patients: National Data Bank for Rheumatic Diseases experience.

Trial Profile

A study evaluating associations of biologic and small-molecule therapies with incident cancer in rheumatoid arthritis patients: National Data Bank for Rheumatic Diseases experience.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jan 2017

At a glance

  • Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Disease-modifying antirheumatics (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Methotrexate (Primary) ; Rituximab (Primary) ; Tocilizumab (Primary) ; Tofacitinib (Primary) ; Tumour necrosis factor (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top